NCT05685004 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05685004
Title	Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	TVAX Biomedical
Indications	glioblastoma
Therapies	Temozolomide Temozolomide + TVI-Brain-1
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 8 of 8 entries

Facility	City	State	Zip	Country	Details
Aaron Mammoser	Atlanta	Georgia	30309	United States	Details
Capital Health	Pennington	New Jersey	08534	United States	Details
Cedar-Sanai Medical Center	Los Angeles	California	90048	United States	Details
Center for Neurosciences	Tucson	Arizona	85718	United States	Details
Moffitt Cancer Center	Tampa	Florida	33612	United States	Details
Providence St. Vincent	Portland	Oregon	97225	United States	Details
University of Kansas Medical Center	Kansas City	Kansas	66061	United States	Details
University of Southern California Keck School of Medicine	Los Angeles	California	90048	United States	Details

Showing 1 to 8 of 8 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05685004Clinical Trial Detail